[Therapy of malignant gammopathies].
D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D006942:Hypergammaglobulinemia / Q000188:drug therapy*; D008558:Melphalan / Q000627:therapeutic use; D009101:Multiple Myeloma / Q000188:drug therapy; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D009983:Orthopedic Equipment; D010266:Paraproteins / Q000032:analysis; D010954:Plasmacytoma / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D014750:Vincristine / Q000627:therapeutic use; D008258:Waldenstrom Macroglobulinemia / Q000188:drug therapy
D009607:Nitrosourea Compounds; D010266:Paraproteins; D002699:Chlorambucil; D014750:Vincristine; D003520:Cyclophosphamide; D008558:Melphalan; D011241:Prednisone
Therapie der malignen Gammopathien.